250 related articles for article (PubMed ID: 24183850)
1. Cancer epigenetics as biomarkers of clinical significance.
Panayiotidis MI
Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850
[No Abstract] [Full Text] [Related]
2. Epigenetic biomarkers in lung cancer.
Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
[TBL] [Abstract][Full Text] [Related]
3. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
Fukushige S; Horii A
Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing applications in cancer research.
Zhang W; Nykter M; Chen K
Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
[No Abstract] [Full Text] [Related]
5. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
7. Screening in GI Cancers: The Role of Genetics.
Stoffel EM
J Clin Oncol; 2015 Jun; 33(16):1721-8. PubMed ID: 25918283
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics in human gliomas.
Kreth S; Thon N; Kreth FW
Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers for cancer prognosis and treatment: have we struck gold?
Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
11. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.
Feng H; Qin Z; Zhang X
Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057
[TBL] [Abstract][Full Text] [Related]
12. Cancer omics: from regulatory networks to clinical outcomes.
Tang B; Hsu PY; Huang TH; Jin VX
Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic biomarkers in cancer epidemiology.
Verma M
Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as promising biomarkers for diagnosing human cancer.
Huang Y; Yang S; Zhang J; Tan L; Jiang F; Li N; Cheng J; Lu Y; Dai Y
Cancer Invest; 2010 Jul; 28(6):670-1. PubMed ID: 20210518
[No Abstract] [Full Text] [Related]
16. Cancer: an epigenetic landscape.
Dhanasekaran K; Arif M; Kundu TK
Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
[No Abstract] [Full Text] [Related]
17. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
19. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
Horswell S; Matthews N; Swanton C
Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer epigenetics: complex simplicity.
van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
